Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Rectal cancer
Trial Type:  Prevention
Results 1-10 of 10 for your search:
Start Over
Eflornithine and/or Sulindac in Preventing Recurrence of High-Risk Adenomas and Second Primary Disease in Patients with Stage 0-III Colon or Rectal Cancer
Phase: Phase III
Type: Prevention
Age: 18 and over
Trial IDs: S0820, NCI-2012-02067, SWOG-S0820, NCT01349881
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Age: Not specified
Trial IDs: CPP-FAP-310, NCI-2013-01805, NCT01483144
Efficacy and Safety of E-101 Solution for Preventing Surgical Site Infections After Colorectal Surgery
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: E-101:PH3:2012:004, NCI-2014-00786, NCT01297959
Fish Oil in Preventing Colorectal Cancer in Participants Previously Diagnosed with Colon Polyps
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 40 to 79
Trial IDs: VICC GI 14138, NCI-2015-00480, 11165, GI 14138, NCI-2015-00070, NCT01661764
Vaccine Therapy in Treating Patients with Newly Diagnosed Advanced Colon Polyps
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 40 to 70
Trial IDs: MAY2013-01-01, NCI-2014-01080, HHSN261201200042I, N01-CN-2012-00042, NCT02134925
Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients with Lynch Syndrome
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: 2013-0698, NCI-2014-00046, HHSN26100003; RFP B, HHSN261201200034I, MDACC-2013-0698, N01-CN-2012-00034, NCT02048735, MDA2013-01-02, NCT02052908
Berberine Chloride in Treating Patients with Ulcerative Colitis in Remission
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 to 70
Trial IDs: NCI 2014-03-01, NCI-2015-00173, NWU2014-03-01, NCT02365480
Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 to 65
Trial IDs: MAY2012-00-01, NCI-2013-01788, 13-829, HHSN2512012000042I, HHSN261201200042I, N01-CN-2012-00042, NCT01912079, NCT01950403
Narrative or Fact-Based Videos in Increasing Colorectal Cancer Screenings in African American Communities
Phase: No phase specified
Type: Behavioral study, Prevention
Age: 18 and over
Trial IDs: I 159309, NCI-2013-01707, RPCI # I 159309, NCT02100254
Aspirin in Preventing Colorectal Cancer in Patients Who Have Undergone Colonoscopy and Adenoma Removal
Phase: No phase specified
Type: Prevention
Age: 18 to 80
Trial IDs: 14-496, NCI-2015-00626, NCT02394769
Start Over